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140Objective:Whether to graft a moderately stenosed coronary vessel remains debatable. We investigated whether
grafting such vessels is warranted based on angiographic evidence of disease progression.
Methods: Of 619 patients who underwent on-pump coronary artery bypass grafting in an ongoing, randomized
radial artery trial, 405 have at least 1 follow-up angiogram at a mean of 6.2 3.1 years (range, 0-14 years) after
surgery. Percent diameter stenosis in each major native vessel was reported by 3 cardiac specialists and classified
as either moderate (40%-69%) or severe (70%) stenosis. Progression of native vessel disease and graft
patency were determined by comparison of pre- and postoperative angiography.
Results: A total of 3816 native vessels and 1242 bypass grafts were analyzed, of which 386 moderate preoper-
ative lesions were identified, 323 of which were grafted. In all territories, grafted vessels had greater risk of dis-
ease progression than ungrafted equivalents (43.4% vs 10.5%, P<.001). Moderate lesions were more likely
than severe lesions to remain unchanged on follow-up angiography (52.6% vs 31.1%, P<.001). Only 1 in 7
moderate lesions in the right coronary artery exhibited significant progression during follow-up if left ungrafted,
whereas the likelihood of progression in left-sided counterparts approached 50%. Arterial and vein grafts to left-
sided moderately stenosed vessels had excellent patency (83% and 77% at 8 years, respectively), which was not
matched by right-sided grafts (P¼ .051). Placement of a graft for a moderate lesion was associated with signif-
icantly greater incidence of disease progression, most marked in the right coronary territory.
Conclusions: The greater risk of progression of left-sided moderate lesions, and high graft patency rates when
bypassed, suggests that the balance of clinical judgment lies in favor of grafting moderate left-sided lesions. In
the right coronary system, however, a lesion is likely to remain moderate if left ungrafted and, with a low risk of
progression, it may be reasonable to leave these vessels undisturbed. (J Thorac Cardiovasc Surg 2013;145:140-9)Recent trials and database analyses of long-term outcomes
following coronary revascularization have reinforced the
place of coronary artery surgery as the gold standard ther-
apy for multivessel disease.1 Most patients referred for sur-
gery have severe disease unsuitable or unfavorable for
percutaneous intervention. Many of these patients will
also have 1 or more moderate lesions, with luminal stenosis
estimated around 50%, and surgeons frequently have to de-
cide whether such vessels require bypass grafting. Studies
of the assessment of fractional flow reserve in moderatee Department of Cardiac Surgery,a Austin Health, Melbourne, Australia; the
l of Medicine,b University of Melbourne, Melbourne, Australia; and the De-
ent of Cardiology,c Austin Health, Melbourne, Australia.
res: Authors have nothing to disclose with regard to commercial support.
the 92nd Annual Meeting of The American Association for Thoracic Sur-
San Francisco, California, April 28-May 2, 2012.
d for publication May 25, 2012; revisions received Sept 3, 2012; accepted for
ation Sept 20, 2012; available ahead of print Oct 18, 2012.
for reprints: Philip A. Hayward, FRCS, Department of Cardiac Surgery,
n Hospital, 145 Studley Rd, Heidelberg, Victoria 3084, Australia (E-mail:
hayward@yahoo.com).
23/$36.00
Copyright  2013 Published by Elsevier Inc. on behalf of The American
tion for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.09.050
The Journal of Thoracic and Cardiovascular Surglesions, largely used to guide requirement for placement
of coronary stents, have suggested that the majority are
not flow limiting in their moderate state,2 so the decision
to graft is based primarily upon anticipation of further pro-
gression to greater severity.
The choice that the surgeon must make depends, in es-
sence, on 3 judgments: the likelihood of progressing to severe
stenosis or occlusion, the likelihood of the lesion remaining
static or regressing, and the outcome (patency) of a graft
placed to such a moderate lesion (which in itself depends
on the conduit used and location of the target artery). This de-
cision is likely affected by other factors, such as how many
other severe lesions require grafting or which other cardiac
procedures need to be performed, because containment of
the cardiopulmonary bypass or aortic crossclamp time and to-
tal operative timemay be a priority in practice, and there may
not be adequate conduit to bypass every diseased vessel.
Existing data on which the surgeon must make these
judgments is conflicting, and much of the data predate mod-
ern secondary prevention therapy, such as the widespread
use of statin and antiplatelet therapy. In some studies,
follow-up angiography may have been prompted by recur-
rence of symptoms, which may result in a bias andery c January 2013
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CASS ¼ Coronary Artery Surgery Study
DEFER ¼ Deferral of Percutaneous Coronary
Intervention study
FAME ¼ Fractional Flow Reserve Versus
Angiography for Multivessel Evaluation
study
FFR ¼ fractional flow reserve
PCI ¼ percutaneous coronary intervention
PNVD ¼ progression of native vessel disease
RAPCO ¼ Radial Artery Patency and Clinical
Outcomes trial
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sion of native vessel disease (PNVD).
In an attempt to provide contemporary data to inform this
decision, we sought to compare pre- and postoperative an-
giograms undertaken as part of a randomized trial of
arterial and venous conduits, with a program of protocol-
driven angiography up to 10 years after surgery, in conjunc-
tion with regular surgical and cardiologic follow-up. The
fate of moderate lesions in these patients offers some insight
that may inform the decision making of the surgeon today.
METHODS
This study derives from the Radial Artery Patency and Clinical Out-
comes (RAPCO) trial, the design of which has been published elsewhere.3
The primary aim of RAPCO is to assess the long-term patency and clinical
outcomes of the radial artery, right internal thoracic artery, and saphenous
vein when grafted to the largest non–left anterior descending artery target.
The RAPCO Trial enrolled a total of 619 patients for coronary bypass sur-
gery using cardiopulmonary bypass, and all patients received the gold stan-
dard in situ left internal thoracic artery to the left anterior descending
artery.
Patients receive annual telephone and clinical reviews for at least 10
years after surgery. Using a second random assignment, protocol-
directed angiograms were allocated at intervals of 1, 2, 5, 7, and 10 years,
with the bulk weighted to the second half of the follow-up because this was
anticipated to coincide with the majority of graft occlusion events. In addi-
tion, elective angiograms at the 5- and 10-year marks were offered to all
patients. All angiograms are reported independently by 3 coronary special-
ists. Graft failure is defined as occlusion,>80% stenosis, or string sign, and
is recorded along with any pathologic findings at the proximal or distal
anastomoses. Any disputed findings are assessed further by a fourth inde-
pendent observer. Severity of native vessel disease is assessed similarly by
the 3 observers, with the native vessels divided into proximal, mid, and dis-
tal sections, and the location and percent stenosis recorded. The latter is re-
corded in the database as the mean of the 3 estimations. In addition to the
percent stenosis, lesions have been ascribed a grade that we have used to
group lesions of similar severity or functional significance, because we
noted a pattern with which observers consistently classify the same lesions
with a particular percentage, depending on whether the lesion is nonflow
limiting (grade 0), moderate (grade 1), flow limiting (grade 2), severe or
subtotally occlusive (grade 3), and totally occlusive (grade 4). Grade 0 is
0% to 39% stenosis, grade 1 is 40% to 69%, grade 2 is 70% to 80%, grade
3 is 81% to 99%, and grade 4 represents total occlusion. Vessels recordedThe Journal of Thoracic and Cawere the left main stem, left anterior descending and each diagonal branch,
circumflex and each obtuse marginal branch, right coronary, posterior de-
scending, and posterolateral branch. Computerized quantitative assessment
was not performed as part of the trial, because this was intended to be
a pragmatic study replicating real-life practice, in which computerized
quantitative assessment is not used widely in Australia.
All patients in RAPCO who have undergone at least 1 postoperative an-
giogram were included in this study, and each of their coronary artery
branches formed a unique data point. By researching the database, the
severity of each native vessel lesion was compared in the preoperative
and postoperative angiograms (or most recent postoperative angiogram
when more than 1 exists), and the duration of imaging follow-up was cal-
culated. Change in severity of the stenosis was recorded together with the
presence, type, and patency of any graft to the vessel noted. Change ofmore
than 1 grade, or to occlusion, was defined as PNVD. If a native vessel lesion
changed by>1 grade, the angiograms were reviewed to check that the same
lesion was being compared. Similarly, any incidence of regression was
reviewed.
Statistical analysis was performed using SPSS software (SPSS Statistics
19; IBM Corporation, Somers, NY). Dichotomous variables were analyzed
using the Pearson c2 test, and continuous variables were analyzed using the
Student t test. The Cox proportional hazards regression model was used to
assess for independent predictors of disease progression. Graft patency was
estimated by the Kaplan-Meier method and the log-rank was test used to
test for differences between groups.
All patients consented to the surgery, angiograms, annual telephone
follow-up, and surgical reviews. The RAPCO protocol was approved by
the Austin Hospital Human Research Ethics Committee (project no.
H95/086). Further approval was gained for this project as a substudy within
RAPCO (December 3, 2008, project no. H2006/02690).RESULTS
Of the 619 patients originally enrolled in RAPCO, 405
had undergone at least 1 protocol, elective or symptom-
directed angiogram, postoperatively. Mean duration of
follow-up was 6.17 years (range, 0-14 years). A total of
3816 native coronary artery branches were identified, of
which 386 contained at least 1 moderate lesion on the pre-
operative angiogram (40%-69% stenosis), and 1356 ves-
sels were significantly stenosed (defined as flow limiting
or severe stenosis, luminal diameter narrowed by 70%).
Patients received 800 arterial grafts and 442 saphenous
vein grafts, functionally bypassing a total of 1940 native
coronary vessels, as some grafts backfilled more than 1 cor-
onary artery branch. Grafting of undiseased vessels oc-
curred when grafts were placed to healthy distal branches
in the presence of isolated proximal disease in the common
stem—for example, in isolated left main stem stenosis.Change in Native Vessel Disease
Table 1 shows the likelihood of progression, regression,
or stability of a moderate or severe coronary lesion on
follow-up angiography. In the overall cohort of native ves-
sels (ranging from no stenosis to complete occlusion preop-
eratively), rates of progression, regression, and stability
were 27.2%, 9.0%, and 63.8%, respectively. Severe lesions
(stenosis  70%) were at higher risk of progressive athero-
sclerosis (46.7% vs 36.3%,P<.001) and were less likely tordiovascular Surgery c Volume 145, Number 1 141
TABLE 1. Trends of disease progression, regression, and stability in
moderate and severe lesions
Native vessel disease
Overall
(0%-100%)
Moderate
(40%-69%)
Severe
(70%)
P value
(moderate
vs severe)
All, n 3816 386 1356
Progression, n (%) 1038 (27.2) 140 (36.3) 633 (46.7) <.001
Regression, n (%) 344 (9.0) 43 (11.1) 301 (22.2) <.001
No change, n (%) 2434 (63.8) 203 (52.6) 422 (31.1) <.001
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erately stenosed counterparts. This significant difference
was confirmed on Kaplan-Meier analysis, shown in
Figure 1, which pools the right and left circulations and
grafted verses ungrafted vessels, and demonstrates the
time course of progression.
Tables 2 and 3 separate bypassed and nonbypassed ves-
sels according to lesion severity, and left and right coronary
circulations. This illustrates a relatively constant preva-
lence of disease progression on the left side, regardless
of moderate or severe stenosis and of the presence or ab-
sence of a bypass graft. In the right coronary circulation,
however, the prevalence of progression is markedly differ-
ent between moderate and severe lesions and is influenced
strongly by coronary grafting in vessels with moderate
stenosis.FIGURE 1. Progression of native vessel disease: severely versus moderately s
PNVD, Progression of native vessel disease; Log rank ¼ 0.021.
142 The Journal of Thoracic and Cardiovascular SurgInfluence of Grafting on Native Vessel Disease
Overall, bypassed native vessels were more likely to
exhibit change (Table 2), with greater risk of disease pro-
gression and regression compared with their ungrafted
counterparts (43.4% vs 10.5%, P< .001, and 15.2% vs
2.61%, P < .001, respectively). This was true in both
the left and right circulations. Correspondingly, native ves-
sels that were not bypassed were more likely to remain
unchanged over long-term follow-up, with 86.9% of non-
bypassed vessels remaining in status quo compared with
41.4% of bypassed vessels (P<.001). Multivariate analy-
sis (Table 4) confirms that the presence of a bypass graft is
an independent predictor for progression of disease in the
left and right territories (hazard ratio for disease progres-
sion, 3.28 and 6.35, respectively, P<.001 for both).
Stability of Moderate (40%-69%) Lesions
In moderate lesions, the effect of bypassing a vessel on
its disease progression appears dependent on target site.
Bypassed moderate vessels in the right circulation showed
greater progressive disease than their ungrafted counter-
parts (40.2% vs 13.8%, P ¼ .008) and lesser stability
(52.0% vs 75.9%, P ¼ .022). In contrast, bypassing
a moderate lesion in the left coronary system did not influ-
ence significantly its risk of disease progression (35.7% vs
47.1%, P ¼ .204, for bypassed and nonbypassed moderate
left-sided lesions).tenosed vessels (pooled right and left, bypassed and nonbypassed vessels).
ery c January 2013
TABLE 2. Influence of bypass grafting, severity of stenosis, and lesion
location on disease behavior
Native vessel disease severity Bypassed Nonbypassed P value
All vessels
All, n 1940 1876
Progression, n (%) 841 (43.4) 197 (10.5) <.001
Regression, n (%) 295 (15.2) 49 (2.61) <.001
No change, n (%) 804 (41.4) 1630 (86.9) <.001
Right circulation, n 559 656
Progression, n (%) 347 (62.1) 66 (10.1) <.001
Regression, n (%) 64 (11.4) 14 (2.1) <.001
No change, n (%) 148 (26.5) 576 (87.8) <.001
Left circulation, n 1381 1220
Progression, n (%) 494 (35.8)* 131 (10.7) <.001
Regression, n (%) 231 (16.7)y 35 (2.9) <.001
No change, n (%) 656 (47.5)* 1054 (86.4) <.001
Severe stenosis (70%), n 1200 156
Progression, n (%) 568 (47.3) 65 (41.7) .182
Regression, n (%) 261 (21.8) 40 (25.6) .271
No change, n (%) 371 (30.9) 51 (32.7) .652
Moderate stenosis (40%-69%), n 323 63
Progression, n (%) 120 (37.2) 20 (31.7) .414
Regression, n (%) 34 (10.5) 9 (14.3) .386
No change, n (%) 169 (52.3) 34 (54.0) .811
Undiseased vessels, n 406 1650
Progression, n (%) 145 (35.7) 109 (6.6) <.001
No change, n (%) 264 (64.3) 1541 (93.4) <.001
*P< .001 when compared with the right circulation with an equivalent degree of
stenosis. yP<.05 when compared with the right circulation with an equivalent degree
of stenosis.
TABLE 3. Prevalence of disease progression according to location,
severity, and presence or absence of a bypass graft
Left-/right-sided lesions Bypassed Nonbypassed P value
Left severe stenosis, n 823 101
Progression, (%) 325 (39.5)* 31 (30.7)* .086
Regression, (%) 205 (24.9)* 29 (28.7) .407
No change, (%) 293 (35.6)* 41 (40.6)y .324
Left moderate stenosis, 221 34
Progression, (%) 79 (35.7) 16 (47.1)y .204
Regression, (%) 26 (11.8) 6 (17.6) .335
No change, (%) 116 (52.5) 12 (35.3)* .062
Left undiseased vessels, n 330 1082
Progression, (%) 85 (25.8)* 83 (7.7)y <.001
No change, (%) 245 (74.2)* 999 (92.3)y <.001
Right severe stenosis, n 377 55
Progression, (%) 243 (64.5) 34 (61.8) .703
Regression, (%) 56 (14.9) 11 (20.0) .325
No change, (%) 78 (20.7) 10 (18.2) .666
Right moderate stenosis, n 102 29
Progression, (%) 41 (40.2) 4 (13.8) .008
Regression, (%) 8 (7.8) 3 (10.3) .668
No change, (%) 53 (52.0) 22 (75.9) .022
Right undiseased vessels, n 76 568
Progression, (%) 60 (78.9) 26 (4.6) <.001
No change, (%) 16 (21.1) 542 (95.4) <.001
*P<.001 when compared with the right circulation with an equivalent degree of ste-
nosis. yP<.05 when compared with the right circulation with an equivalent degree of
stenosis.
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exhibited a different pattern of disease behavior when com-
paring the left with the right. The right circulation was
more stable, with a lower incidence of disease progression
(13.8%vs47.1%,P¼ .005), andmorevessels remaining un-
changed (75.9% vs 35.3%, P<.001) than the left (Table 3).Development of New Disease
It is notable from Table 2 that when disease-free vessels
are bypassed (usually because they lie distal to a more dis-
eased vessel that requires grafting and therefore become
a potential meeting point for flow from the native circula-
tion and the bypass conduit), the risk of development of
flow-limiting disease in a previously healthy vessel is in-
creased approximately 5-fold compared with ungrafted
healthy vessels. And just as for bypassed moderate lesions,
the right coronary system seems more vulnerable, with
a 17-fold increase in disease development in bypassed
undiseased branches (Table 3).Patency of Grafts Anastomosed to Moderately
Stenosed Native Vessels
Patency of grafts anastomosed to moderately stenosed
native vessels is summarized in Figures 2 and 3. OverallThe Journal of Thoracic and Cagraft survival in the left circulation was 83.2% after 8 years
of follow-up. There was a trend to inferior graft patency in
the right circulation—73.3% at 7 years (P¼ .051). Surpris-
ingly, despite being grafted to moderately stenosed vessels,
arterial conduits showed excellent patency in the left circu-
lation (83% at 8 years). Comparison with arterial grafts
placed to the right circulation is not meaningful because
of inadequate numbers (n ¼ 13), but is estimated at 75%
at 2 years. Vein grafts show similar patency in the left and
right circulations (77% at 8 years and 72% at 7 years,
respectively), and numbers are insufficient to detect any
difference between them.Impact on Clinical Outcome of Grafting Moderate
Lesions
There was no significant difference in the requirement
for subsequent revascularization during follow-up of mod-
erate lesions depending on whether they were grafted not,
although there were arguably too few revascularization
events for meaningful analysis (Table 5). Among moderate
left-sided lesions, only 2 grafted vessels and 1 ungrafted
vessel required revascularization (P ¼ .31), and among
right-sided lesions the incidence was 2 grafted and 2 un-
grafted (P ¼ .17). Survival was not affected by grafting or
nongrafting of a moderate lesion. Data regarding angina
recurrence were not recorded.rdiovascular Surgery c Volume 145, Number 1 143
TABLE 4. Multivariate Cox proportional regression model for predictors of disease progression
Predictors of disease
progression
All vessels in
left circulation
(n ¼ 2601)
All vessels in
right circulation
(n ¼ 1215)
All moderate
vessels (n ¼ 386)
Bypassed
moderate vessels
(n ¼ 323)
Nonbypassed
moderate vessels
(n ¼ 63)
HR P value HR P value HR P value HR P value HR P value
Age 1.02 .002 1.01 .041 1.02 .043 1.03 .010 1.02 .632
Sex, male 1.26 .097 1.00 .983 0.99 .981 1.05 .911 0.77 .761
Hypertension 1.22 .017 1.07 .524 1.47 .038 1.23 .376 1.83 .362
Diabetes mellitus 1.06 .544 0.98 .863 1.05 .798 1.40 .169 0.68 .530
Smoking, current 0.71 .065 1.22 .357 0.84 .649 1.08 .892 0.38 .387
Bypassed vessel 3.28 <.001 6.35 <.001 1.69 .043 — — — —
Circulation, right — — — — 1.17 .406 1.78 .041 0.23 .014
Presence of arterial graft 1.16* .150 0.664* .001 — — 1.02 .928 — —
HR, Hazard ratio. *Hazard ratio for presence of arterial graft is calculated only for bypassed native vessels (n ¼ 1381 in left circulation and n ¼ 559 in right circulation). Right
circulation ¼ right coronary artery (RCA) þ posterior descending artery (PDA) þ left ventricular branch (LV Br). Left circulation ¼ left anterior descending (LAD) þ first
diagonal branch (D1) þ second diagonal branch (D2), left circumflex (LCx) þ first obtuse marginal (OM1) þ second obtuse marginal (OM2), intermediate.
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Vessel Disease
Comparison of patients<70 years and 70 years did
not show a significant difference in disease progression, al-
though older patients were more like to experience regres-
sion of a lesion (Table 6). In the multivariate analysis,
increasing age was an independent risk factor for progres-
sion, together with hypertension and the presence of a graft.
Thiswas true for both the left and right circulations (Table 4).
The use of an arterial graft for a lesion in the right circulation
(largely severe) was protective against PNVD, an effect not
replicated on the left side.
Multivariate analysis of moderate lesions (Table 4)
confirms that bypassed moderate lesions in the right coro-
nary system were more likely to progress than their left-
sided counterparts (hazard ratio for disease progression,
1.78; P ¼ .041), but nonbypassed moderate vessels were
more stable on the right side, with a 77% decreased risk of
disease progression on the right (hazard ratio, 0.23;
P ¼ .014). The type of bypass conduit did not affect the
odds of disease progression in moderately stenosed vessels.
DISCUSSION
The decision to graft or leave a moderately stenosed vessel
during a cardiac surgical procedure depends on a number of
calculations by the surgeon. In clinical practice, the balance
of these estimations of the future of both the lesion and any
graft placed to that territory, must be weighed against other
surgical considerations, such as the availability of conduit,
the number of grafts, and other operative procedures needed,
such as valvular or aortic repair. Facedwith amoderate lesion,
the surgeonmight commonly choose between leaving it alone
or placing a saphenous vein bypass, given that arterial grafts
have been reported to show lower patency as a result of com-
petitive flow in lesions with<70% stenosis.4-7
The results presented here offer some contemporary data
on which to base this decision, taking into account the144 The Journal of Thoracic and Cardiovascular Surgpotential impact of secondary prevention measures and
the influence exerted by grafting. A number of conclusions
present themselves: (1) that an ungrafted right-sided moder-
ate lesion is less likely to progress than its left-sided coun-
terpart, and that it has a very low hazard for progression on
multivariate analysis, but that the chances of lesion progres-
sion are substantially increased if a graft is placed to this ter-
ritory; and (2) that the patency of an arterial or venous graft
to the moderately diseased left-sided target is relatively
good at 7 to 8 years, which is possibly superior to that of
right-sided grafts to similar lesions (P ¼ .051). There was
no correlation with age, despite the attraction of shortening
bypass times in elderly patients by avoiding excessive
grafting.
From these findings, one might argue in favor of grafting
a left-sided moderate lesion with whatever conduit the sur-
geon prefers, given that the risk of progression is higher and
the outcome of the graft is likely to be good, but leaving
a right-sided lesion alone, given the low risk of progression
if left undisturbed. The limited clinical outcome data do not
record angina recurrence, but they do show a low event rate
for subsequent revascularization of a moderately stenosed
vessel during follow-up after coronary artery bypass graft-
ing (CABG), regardless of whether it is grafted , and from
this one might argue in favor of leaving all moderate le-
sions. However, with angiographic progression seen in al-
most half of such lesions on the left side, we suggest that
these should be best addressed during CABG. Our finding
of equivalent patency for arterial and venous grafts placed
to such moderate left-sided lesions is surprising, but if cor-
rect may widen the scope of conduit availability for the
moderately stenosed vessel on this side.
Studies of fractional flow reserve (FFR) suggest that the
key question here is not the current impact on flow of a mod-
erate lesion, but rather the likelihood of subsequent progres-
sion. For example, in the Deferral of Percutaneous
Coronary Intervention (DEFER) study,2 FFR of moderatelyery c January 2013
FIGURE 2. Patency of all grafts to left and right circulations (moderately stenosed vessels). *Log rank ¼ .051.
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flow limitation (ie, ischemia) was shown in a minority of
such lesions only. When these were randomized to medical
therapy or intervention, the risk of clinical events in medi-
cally managed patients was only 1% per annum, and lower
than if percutaneous coronary intervention (PCI) was per-
formed for the moderate lesion. It can be argued that the
presence of an intracoronary stent for a lesion that is not
flow limiting represents a greater risk to the patient, in terms
of stent thrombosis and myocardial infarction, than a spuri-
ous bypass graft. However, the high incidence of progres-
sion of right coronary disease following bypass of
moderate right coronary lesions suggests that these grafts
may not be harmless either, as increased progressive disease
leaves the patient dependent on graft flow for a territory, and
the graft may undergo progressive degeneration.
Similarly, the Fractional Flow Reserve Versus Angiogra-
phy for Multivessel Evaluation (FAME) study randomized
participants to percutaneous revascularization guided by
physiologic flow reserve or by anatomic stenosis derived
by angiography.8 Primary and composite end points were
superior when a functional assessment was used to guide re-
quirement for PCI. Studies such as FAME and DEFER haveThe Journal of Thoracic and Cahighlighted that physiologic (flow) data are more important
than anatomic stenosis, on which most of the surgical liter-
ature is centered.
Ideally, coronary grafting could be directed similarly by
pressure or flow data. Yet even if we are able to identify the
flow limiting lesions correctly and then bypass them, the
best management of the nonflow-limiting moderately ste-
nosed counterpart still depends on the likelihood of progres-
sion, and it is here that our data may assist in the clinical
decision.
Earlier important studies of PNVD and of the impact of
coronary grafting have been published elsewhere, but
most of these studies predate modern multifaceted second-
ary prevention by statins, angiotensin-converting enzyme
inhibition, and antiplatelet therapy, with their pleiotropic ef-
fects on plaque stabilization, inflammation, lipid accumula-
tion, platelet adhesion, and vascular smooth muscle
function. This may account for some differences in our find-
ings, but several similarities persist. Our finding that moder-
ate lesions are more stable than severe lesions was first
described 30 years ago in a study showing similar relation-
ships between progression in lesions of lesser or greater se-
verity, even without the significant advances in secondaryrdiovascular Surgery c Volume 145, Number 1 145
FIGURE 3. A and B, Patency of arterial and vein grafts to left (A) and right (B) circulations (moderately stenosed vessels).
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mark Coronary Artery Surgery Study (CASS)10 also di-
vided coronary lesions into grades of severity, and the risk
of progression/occlusion was shown to increase with each
increase in grade of stenosis, an observation that was repli-
cated byMalinow and colleagues11 in a smaller study of 100
patients.
Similarly, the observation that bypassing a coronary
artery increases significantly its risk of disease progression
or development of new lesions has been reportedTABLE 5. Moderate vessels: effect of grafting on clinical outcomes
Moderate lesions
Left
Bypassed (n ¼ 221) Nonbypassed (n ¼
Death, n (%) 37 (16.7) 5 (14.7)
Revascularization by vessel, n (%) 2 (0.9) 1 (2.9)
146 The Journal of Thoracic and Cardiovascular Surgelsewhere.9-14 In the 780 patients enrolled in CASS,10 by-
passed segments of native coronary artery were more likely
to progress or occlude compared with nonbypassed seg-
ments, regardless of lesion severity, and the risk of progres-
sion increased with severity of stenosis at baseline
(progression/occlusion rates 11% vs 4.3% for grafted vs un-
grafted nondiseased segments, compared with 39% vs 19%
for grafted vs ungrafted lesser lesions and 54% vs 28% for
severe lesions). Likewise, in the Cholesterol Lowering Ath-
erosclerosis Study,14 native vessels proximal to a graftRight
34) P value Bypassed (n ¼ 102) Nonbypassed (n ¼ 29) P value
.766 13 (12.7) 4 (13.8) .882
.305 2 (2) 2 (6.9) .173
ery c January 2013
TABLE 6. Moderate vessels: disease progression by age and location
Age and vessel location <70 y, n (%) 70 y, n (%) Log rank
All 281 105
Progression 104 (37) 36 (34.3) .418
Regression 24 (8.5) 19 (18.1) .004
No change 153 (54.4) 50 (47.6) .750
Left circulation, n 189 66
Progression 70 (37) 25 (37.9) .115
Regression 18 (9.5) 14 (21.2) .005
No change 101 (53.4) 27 (40.9) .896
Right circulation 92 39
Progression 34 (37) 11 (28.2) .355
Regression 6 (6.5) 5 (12.8) .244
No change 52 (56.5) 23 (59) .923
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The overall disease progression in native coronary arteries
was estimated at 10% at 2 years after surgery, as evaluated
by quantitative coronary angiography, which seems in line
with the progression rate of 27% noted in our data during
longer duration of follow-up (mean, 6.2 years).
Results in our data set are similar to that of the quoted lit-
erature9-14: Bypassing a vessel increases its likelihood of
new lesion development in previously undiseased vessels
and increases its risk of disease progression in moderately
stenosed vessels. It has been suggested that increased
disease progression in bypassed vessels may be attributed
to stasis of blood through the native coronary artery as
a result of competition from a patent graft.15 Our results
also suggest that the excess of disease progression in by-
passed vessels continues beyond the 2-year mark described
in the Cholesterol Lowering Atherosclerosis Study, and that
this occurs despite optimized modern secondary prevention
agents with their numerous pharmacologic effects.
It is noteworthy that none of the series mentioned here re-
ported the particular stability of ungrafted moderate right
coronary lesions that we have found, perhaps because of
the smaller number of ungrafted vessels or because of dif-
ferences in study design. However, it is at least theoretically
possible that this phenomenon has arisen more recently as
a result of modern medical management, which might im-
pact differently on lesions of different severity or different
coronary sites, where patterns of coronary flow are not uni-
form. Nonetheless, it seems more likely that this preponder-
ance of left-sided progression among moderate lesions is
simply an extension of the greater prevalence of atheroscle-
rotic disease in the left coronary circulation compared with
the right coronary circulation, as has been reported in non-
surgical patients,16,17 which might arise from the anatomic
and hemodynamic differences between the right and left
coronary circulations.18 In healthy nonbypassed vessels in
our cohort (n ¼ 1650), the left circulation showed a greater
tendency to develop de novo disease (7.7% vs 4.6%,
P<.05), consistent with patterns of lesion distribution inThe Journal of Thoracic and Caother reports.12,13 Therefore, our data suggest that
nonbypassed moderate lesions are behaving in a similar
fashion to undiseased vessels, with a preponderance of
left-sided progression and low risk of disease progression
for the moderate right-sided lesion.
It is interesting that our data show right coronary vessels
with>70% stenosis to exhibit a higher rate of disease pro-
gression than their left equivalents, suggesting perhaps a dif-
ferent natural history of advanced right coronary disease. In
other words, although moderate right-sided lesions appear
quite stable if left alone, severe lesions seem the opposite.
This seems hard to explain, unless progression by athero-
sclerosis is linear on the left and exponential on the right,
perhaps relating to differences in physiology and flow.
This is speculative and has not been reported elsewhere.
Direct comparisons with other studies present a challenge
because of different study populations, methodology,
and definitions of disease severity and progression. For
example, within CASS, the definition of severe stenosis
was 50% stenosis; therefore, the disease behavior of
this group may, in fact, be a mixture of that of our moder-
ately stenosed (40%-69%) and severely stenosed groups.
Limitations
There are number of limitations to this study that we ac-
knowledge. The power of our analysis is limited by the
number of patients who have, to date, undergone pre- and
postoperative angiography (n ¼ 405). A larger sample
size may have elicited other significant factors relevant to
the PNVD. Although the recorded percent stenosis is the
mean of several estimations by independent observers,
a more accurate estimation of disease progression could
be obtained by formal quantitative angiography. The addi-
tion of physiologic data from measurements of FFR would
offer the gold standard of assessment of moderate lesions in
current practice, but is not in widespread clinical use and
has not been performed in this patient cohort.
Details of lesion topography (ulceration vs smooth con-
tour, concentricity vs eccentricity, presence or absence of
thrombus) is not recorded in our data set but may be relevant
to clinical outcome and surgical decision making in some
cases. Last, requirement for subsequent PCI or surgery is
an incomplete marker for angina recurrence, but incomplete
recording of ischemic symptoms in our clinical follow-up
data did not allow safe correlation of these with angio-
graphic progression, with which only revascularization
events (as a surrogate for ischemia) could be compared.
CONCLUSIONS
Data from postoperative angiography in predominantly
asymptomatic patients receiving contemporary secondary
prevention therapies suggests that moderate lesions in the
left coronary system are best treated by bypass grafting dur-
ing multivessel revascularization, whereas right-sidedrdiovascular Surgery c Volume 145, Number 1 147
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Dlesions may reasonably be left alone because they are un-
likely to progress and are not likely to require subsequent
revascularization. These data may assist coronary surgeons
in a common clinical dilemma.
Wewould like to acknowledge the contribution of Miss Kristine
Teoh (National University Hospital, Singapore) in the original
conception of this study.References
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Dr Joseph F. Sabik (Cleveland, Ohio). Dr Smith, Dr Sundt,
members, and guests, in this paper by Dr Hayward and col-
leagues, they address whether coronary arteries with moderate
stenosis or nonischemia-producing lesions should be bypassed
routinely during coronary artery bypass surgery. They conclude,
as a result of the low rate of disease progression and low arterial
graft patency, that it may be best not to bypass routinely right
coronary arteries with moderate stenosis. They come to a very
different conclusion for left-sided coronary arteries. Because
the rate of disease progression is higher and the patency of arte-
rial grafts performed to left-sided coronary arteries with moder-
ate stenosis is excellent, they suggest that routinely bypassing
left-sided coronary arteries with only moderate lesions may be
appropriate.
This study is timely and important, especially in light of recent
findings from the interventional study, FAME. In FAME,
FFR-guided percutaneous coronary revascularization resulted in
a 25% decrease in the combined end points of death, myocardial
infarction, need for CABG, or repeat PCI. In other words,
stenting moderate, or nonischemia-producing coronary artery
stenosis, resulted in worse clinical outcomes. Might this also be
true for routinely grafting coronary arteries with only moderate
or nonischemia-producing lesions? I have 4 questions for Dr
Hayward.
Although knowing how grafting influences coronary artery ste-
nosis progression in moderate lesions is interesting and suggestive,
to decide whether to graft coronary arteries with moderate stenosis
requires clinical outcomes data. Did you follow the clinical events
in these patients and, if you did, do you know if grafting moderate
coronary artery lesions resulted in poorer long-term outcomes?
Also, did it matter whether the grafted coronary with a moderate
lesion was right or left sided?
Second question: You observed different rates of lesion progres-
sion in the right and left coronary artery systems; moderately ste-
nosed left-sided coronary arteries have a higher rate of disease
progression than moderately stenosed right coronary arteries. Do
you have an explanation for why disease progression is different
for right- and left-sided coronary arteries?
Third question: Grafting a moderately stenosed coronary artery
clearly resulted in greater lesion progression.Was the rate of lesion
progression different whether an artery or saphenous vein was
used as the bypass conduit?
And last, should we be using FFR guidance in determining
which lesions should be bypassed during coronary artery bypass
surgery? Thank you for the privilege of discussing this paper.
Dr Hayward. Thank you, Dr Sabik, for your comments and
questions. I agree. I think that the data from FAME in interven-
tional cardiology and another study, DEFER, which just looked
at moderate lesions, which we can come back to, are very timely
and in some ways can be extrapolated to this study.
To answer your 4 questions directly, if I have them correctly,
clinical outcome data—I didn’t include the clinical data in this be-
cause (1) we already had a lot of information (this was primarily
intended as a study of angiographic progression) and (2) because
these patients are part of the trial, we reported the mid-term results
at AATS a couple of years ago and we are now awaiting the full
10-year completion data, and I have tried not to overtrawl the trialery c January 2013
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might relate to the overall trial data, because we know the graft
patencies and we know the progression of disease.
However, I can say that on the multivariate analysis, PNVD
overall is not related to the incidence of death, myocardial infarc-
tion, or requirement for revascularization. The hazard ratio for all
of those is in the range of .85 to .15 for those 3 end points. That’s
looking at all vessels. And if you look at moderate vessels, progres-
sion of moderate lesions is not associated on a multivariate analy-
sis with the hazard ratio of death, infarction, or revascularization.
What we haven’t done, however, is divide those moderate vessels
into grafted and ungrafted. The numbers are getting very small
there.
So I cannot answer your question whether grafting a moderate
lesion versus not grafting a moderate lesion will alter the end
points that we have. We do not have recurrent angina as an end
point in our trial, because the trial is limited to the very hard
data points of death, infarction, and requirement for revasculariza-
tion, so I cannot answer that question. But, I can say that those clin-
ical end points are not related significantly to whether you have
progressive or nonprogressive disease on your angiogram.
Dr Sabik. Why that might be is interesting, and as I read your
paper I waswondering: Is this a competing risk problem?Moderate
coronary lesions tend to be the culprit lesions, the lesions that
acutely thrombose and result in myocardial infarctions. Might
these patients be having events if these lesions are not grafted? I be-
lieve a good hard look at the clinical outcomes is necessary to de-
termine whether to graft coronary arteries with moderate stenosis.
Dr Hayward. The second question that you asked is why
should the progression of moderate right lesions be less than on
the left, and I think that’s obviously, if you like, the meaning of
this paper. I don’t have a hypothesis. I guess it may be that the path-
ophysiology of these is different. People have imputed the impact
of lipids and the atherosclerotic burden and also of shear stresses,
and in pathologic studies of autopsies and in, now, the coronary
computed tomographic studies, we know that the burden of coro-
nary disease is higher in the overall population in left-sided rather
than right-sided vessels, and it has been postulated that’s because
left-sided vessels have more shear stresses being related to the left
ventricle because they have a different flow pattern compared with
the right coronary.
So it is possible, I guess, that the modern secondary prevention,
particularly statins, both in their lipid modulatory and anti-inflam-
matory effects, may be exerting a different effect in the right cor-
onary versus the left coronary, because they can modulate the lipid
impact and the inflammatory impact—in other words, the athero-
sclerotic driver—but they can’t alter the shear stresses, which are
driven by the left ventricle essentially. That is the only reason I can
think of why over 20 years, advances in medical therapy might
have left us with these very stable right coronary lesions.
Dr Sabik. I was wondering if this finding is a result of the way
plaque burden was measured. Because increase in coronary ste-
nosis is a result of increase in plaque thickness, by measuring
percentage stenosis and not plaque thickness, I believe your find-
ings may be a result of the differences in the different coronaryThe Journal of Thoracic and Caartery diameters. A millimeter increase in plaque thickness will
have a much greater effect on the percentage stenosis of circum-
flex with a 2-mm diameter then it would on a right coronary
artery with a 5-mm diameter. To determine disease progression
accurately, it may be necessary to determine changes in plaque
size, not just percent stenosis.
Dr Hayward. That is a very good observation. We did not per-
form quantitative analysis, because to go back for 3800 vessels and
perform quantitative analysis would be an enormous task, and we
don’t have funding for the team of people that would be needed to
do that. But I think for these moderate lesions, particularly the un-
grafted moderate lesions, the number is much smaller, and I think
we should go back and do exactly that analysis—do quantitative
analysis—to measure the burden of disease and find out whether
this is, as you say, truly a stability effect of medical therapy or is
it actually an artifact of a bigger vessel. It takes more burden to ste-
nose a bigger vessel. I suspect the former is true, but we can mea-
sure that.
In terms of your third question, which was choice of conduit,
there is no difference in the disease progression on multivariate
analysis between whether you place an arterial or a vein graft,
and that data will be in the manuscript with all the complete
data. But, choice of conduit does not seem to impact on the rate
of progression.
Your fourth question, I think, is whether the use of FFR should
guide these studies, and I think that is the key point. Some of those
moderate lesions are flow limiting; some of them are not. We know
from the DEFER study, which was a study in interventional cardi-
ology of 50% to 70% stenoses, and they performed FFR on those,
only one-third of those lesions had an FFR of<0.75—in other
words, were flow limiting—and the ones that weren’t, they then
randomized to stent or medical management. Not surprisingly,
those patients who got medical management did significantly bet-
ter than those who got a stent. And I think surgeons would recog-
nize that if you put a stent in a vessel that is not actually flow
limiting, that is going to impact on your long-term outcome, be-
cause it represents a lifetime risk for you.
We probably feel that the same is not true of bypass surgery, be-
cause if you put a bypass graft to a vessel and it wasn’t actually
flow limiting, well, the worst that can happen is the graft will
fail and you haven’t done any harm.
And I think what is interesting in our data is that may not be
true, that the findings of FAME and DEFERmight relate to surgery
as well. Putting a bypass to a vessel that doesn’t need it might be a
bad thing, but if you accelerate the disease progression, especially
as you probably put a vein graft to the right coronary—because
you and other authors have documented the worst outcome of ar-
terial grafts on moderate right lesions—if you are going to put
a vein graft, you may accelerate the progression of the native dis-
ease, and that patient then becomes dependent on a graft on the
right side, and that graft is going to have an attrition. So I think
FFR to guide the actual revascularization of these lesions in the
future will be the way to go.
Dr Sabik. Thank you, and congratulations on an excellent
presentation and paper.rdiovascular Surgery c Volume 145, Number 1 149
